The latest research note from the company’s corporate broker, SP Angel, is now available on our web site here

 

Announcements

Publication of Supplementary Prospectus
12 May, 2021
Conversion of Convertible Loan Notes
05 May, 2021
Final Results for the Year Ended 31 December 2020
30 Apr, 2021
View all

Media coverage

Hemogenyx Pharmaceuticals (LON: HEMO) up over 260% as it searches for COVID antibodies
Video >
Investival Conference Presentation November 19, 2019
Video >
Blood Health Q3 2019 – page 11 Hemogenyx Pharmaceuticals feature
Video >
View all

Annual & Half Year Reports

2020 Annual Report Read >

Proxy Form (January 2021 General Meeting) Read >

General Meeting Notice (January 2021) Read >

Circular & General Meeting Notice (December 2020 – withdrawn) Read >

2020 Half Year Report Read >

View all

Share price

View share price and other information on our London Stock Exchange company page

 

LSE: HEMO

Company and share data